Cover Image
市場調查報告書

中東、北非的醫藥品、醫療產業 (季度更新報告)

Middle East And North Africa Pharmaceuticals and Healthcare Report Q4 2017

出版商 BMI Research 商品編碼 361671
出版日期 內容資訊 英文 33 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中東、北非的醫藥品、醫療產業 (季度更新報告) Middle East And North Africa Pharmaceuticals and Healthcare Report Q4 2017
出版日期: 2017年10月18日 內容資訊: 英文 33 Pages
簡介

本報告提供中東、北非 (MENA) 各國的製藥、醫療產業結構和形勢相關分析,最新的市場趨勢 (以季度為基礎) ,及今後的長期性的產業規模的動向估計,產業的課題 (風險) 和未來商機 (利潤) 相關評估,今後的市場成長的機會與課題,域內各國、各地區詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI產業分析

  • 中東、北非市場最新趨勢 (以季度為基礎)

SWOT分析

  • 中東、北非市場最新趨勢 (以季度為基礎)

產業預測

  • 製藥產業:中東、北非市場最新趨勢 (以季度為基礎)
  • 醫療產業:中東、北非市場最新趨勢 (以季度為基礎)

產業的風險/利潤指標

  • 中東、北非市場最新趨勢 (以季度為基礎)

市場概要

  • 中東、北非市場最新趨勢 (以季度為基礎)

產業的趨勢與發展

  • 中東、北非市場最新趨勢 (以季度為基礎)

地區概要

  • 中東、北非市場最新趨勢 (以季度為基礎)

用語一覽

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤、等級技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1040

BMI View: Challenging political and macroeconomic conditions in the MENA region will continue to challenge multinational drugmakers' performance and regional growth. This is dictating a number of strategic developments, including greater stakeholder engagement, new product launches and diversified therapeutic development from firms in the region. Crucially, a country-specific approach is integral for pharmaceutical companies as they must adapt to the evolving pricing landscape, differing levels of patent protection and the level of competition within each market.

Headline Expenditure Projections:

  • Pharmaceuticals: USD31.7bn in 2016 to USD31.6bn in 2017. -0.5% y-o-y in US dollar terms.
  • Healthcare: USD170.2bn in 2016 to USD174.7bn in 2017. 2.7% y-o-y in US dollar terms.

Risk/Reward Index:

The Middle East and North Africa (MENA) region will continue to present a diverse range of opportunities for international drugmakers. While some markets present high growth potential and opportunities for innovative product launches, it is vital that companies appreciate the varying levels of both investment risk and reward that are present in the markets in the region.

Table of Contents

BMI Industry View

  • Middle East And North Africa - Q4 2017
    • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (2015-2021)

SWOT

  • Middle East And North Africa - Q4 2017

Industry Forecast

  • Pharmaceutical - Middle East And North Africa - Q4 2017
    • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts (2013-2021)
  • Healthcare - Middle East And North Africa - Q4 2017
    • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts (2013-2021)
  • Industry Risk Reward Index
  • Middle East & North Africa Risk/Reward Index - Q4 2017

Market Overview

  • Middle East And North Africa - Q4 2017

Regional Overview

  • Middle East & North Africa - Q4 2017
  • Industry Trends And Developments
  • Regional Round-Up - Q3 2017

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top